Literature DB >> 25075

Beta-blockers and asthma.

P B Decalmer, S S Chatterjee, J M Cruickshank, M K Benson, G M Sterling.   

Abstract

In a single-blind, randomised, crossover study in 10 asthmatic patients, the effects of approximately equipotent oral doses of 3 cardioselective beta-blockers-atenolol (100 mg), metoprolol (100 mg), and acebutolol (300 mg)-and 4 non-cardioselective beta-blockers-proranolol (100 mg), oxprenolol (100 mg), pindolol (5 mg), and timolol (10 mg) upon FEV1 were compared. All drugs, except pindolol, produced a significant reduction in standing pulse rate and prevented an increase in heart rate after inhaled isoprenaline (1500 microgram). All drugs caused a fall in FEV1 but only atenolol did not differ significantly from placebo in this respect. The bronchodilator response to inhaled isoprenaline was blocked by the 4 non-cardioselective drugs; the 3 cardioselective agents permitted some bronchodilatation, but only atenolol did not differ from placebo.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25075      PMCID: PMC482795          DOI: 10.1136/hrt.40.2.184

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  9 in total

1.  Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.

Authors:  C Davidson; U Thadani; W Singleton; S H Taylor
Journal:  Br Med J       Date:  1976-07-03

2.  Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.

Authors:  F R Bühler; F Burkart; B E Lütold; M Küng; G Marbet; M Pfisterer
Journal:  Am J Cardiol       Date:  1975-10-31       Impact factor: 2.778

3.  Effect of atenolol on ventilatory and cardiac function in asthma.

Authors:  J S Vilsvik; J Schaanning
Journal:  Br Med J       Date:  1976-08-21

4.  Beta-adrenergic blocking drugs.

Authors:  J W Paterson
Journal:  Br Med J       Date:  1971-06-12

5.  A comparison of the effect on airway resistance of a new beta blocking drug, ICI.50,172 and propranolol.

Authors:  A G Macdonald; R S McNeill
Journal:  Br J Anaesth       Date:  1968-07       Impact factor: 9.166

6.  Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon.

Authors:  J J Lertora; A L Mark; J Johannsen; W R Wilson; F M Abboud
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

7.  A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors.

Authors:  B N Singh; H E Nisbet; E A Harris; R M Whitlock
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

8.  Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.

Authors:  F J Conway; J D Fitzgerald; J McAinsh; D J Rowlands; W T Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

9.  Comparison of adrenergic beta-receptor antagonists in angina pectoris.

Authors:  U Thadani; B Sharma; M K Meeran; P A Majid; W Whitaker; S H Taylor
Journal:  Br Med J       Date:  1973-01-20
  9 in total
  36 in total

1.  Deciphering modern glucocorticoid cross-pharmacology using ancestral corticosteroid receptors.

Authors:  Jeffrey A Kohn; Kirti Deshpande; Eric A Ortlund
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

Review 2.  Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.

Authors:  Y Yamada; K Matsuyama; K Ito; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

Review 3.  Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

4.  Influence of intrinsic sympathomimetic activity on respiratory function during chronic beta blockade: comparison of propranolol and pindolol.

Authors:  R J Northcote; D Ballantyne
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

5.  Comparative effects of dilevalol and atenolol on lung function and airway response to methacholine in hypertensive subjects.

Authors:  L P Boulet; Y Lacourcière; J Milot; N Lampron
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

6.  Exercise responses of healthy subjects in the evaluation of cardioselectivity of beta-blockers.

Authors:  K L Woods; S P Linton; M J Kendall; E B Faragher; R J Grieve
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

Review 7.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

8.  Assessment of beta-adrenoceptor antagonists in asthmatic patients.

Authors:  R E Ruffin; E L McIntyre; K M Latimer; H E Ward; A J Crockett; J H Alpers
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

9.  Asthma and beta-blockers.

Authors:  D S Lawrence; J N Sahay; S S Chatterjee; J M Cruickshank
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.

Authors:  S Groth; P Tønnesen; M Asted; H Dirksen; P G Sørensen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.